AR058293A1 - PROFARMATIC SALTS AND FORMULATIONS OF 1- [5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO [2,3-D] PIRIMIDIN-5-CARBONIL) -2-METOXI-PHENIL] -3- (2,4- DICLOR-PHENYL) - Google Patents
PROFARMATIC SALTS AND FORMULATIONS OF 1- [5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO [2,3-D] PIRIMIDIN-5-CARBONIL) -2-METOXI-PHENIL] -3- (2,4- DICLOR-PHENYL)Info
- Publication number
- AR058293A1 AR058293A1 ARP060105422A ARP060105422A AR058293A1 AR 058293 A1 AR058293 A1 AR 058293A1 AR P060105422 A ARP060105422 A AR P060105422A AR P060105422 A ARP060105422 A AR P060105422A AR 058293 A1 AR058293 A1 AR 058293A1
- Authority
- AR
- Argentina
- Prior art keywords
- profarmatic
- diclor
- isopropil
- carbonil
- phenil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
La presente se refiere a compuestos de la formula (1) o una sal farmacéuticamente aceptable, profármaco o hidratos de los mismos. La presente también se refiere a composiciones farmacéuticas que contienen los compuestos de formula (1) y a métodos para tratar trastornos hiperproliferativos en un mamífero por medio de la administracion de los compuestos de formula (1).This refers to compounds of the formula (1) or a pharmaceutically acceptable salt, prodrug or hydrates thereof. This also refers to pharmaceutical compositions containing the compounds of formula (1) and to methods for treating hyperproliferative disorders in a mammal by administration of the compounds of formula (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74907005P | 2005-12-09 | 2005-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058293A1 true AR058293A1 (en) | 2008-01-30 |
Family
ID=38123252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105422A AR058293A1 (en) | 2005-12-09 | 2006-12-07 | PROFARMATIC SALTS AND FORMULATIONS OF 1- [5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO [2,3-D] PIRIMIDIN-5-CARBONIL) -2-METOXI-PHENIL] -3- (2,4- DICLOR-PHENYL) |
Country Status (8)
Country | Link |
---|---|
AR (1) | AR058293A1 (en) |
DO (1) | DOP2006000271A (en) |
GT (1) | GT200600496A (en) |
NL (1) | NL2000337A1 (en) |
PE (1) | PE20071037A1 (en) |
TW (1) | TW200733965A (en) |
UY (1) | UY29991A1 (en) |
WO (1) | WO2007066189A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009050291A2 (en) * | 2007-10-19 | 2009-04-23 | Abbott Gmbh & Co. Kg | Solid dispersion product of n-aryl urea-based drugs |
CL2008003092A1 (en) * | 2007-10-19 | 2009-11-27 | Abbott Gmbh & Co Kg | Solid dispersion product comprising an active agent derived from n-aryl urea, a matrix-forming agent selected from cyclodextrins, polymers, lipids and a non-ionic surfactant; process for preparing said dispersion product; and a pharmaceutical dosage form comprising it. |
WO2010045542A2 (en) * | 2008-10-16 | 2010-04-22 | The Regents Of The University Of California | Fused ring heteroaryl kinase inhibitors |
BR112012016376A2 (en) | 2009-12-30 | 2019-09-24 | Arqule Inc | substituted pyrrolo-aminopyrimide compounds |
JP5847813B2 (en) * | 2010-06-23 | 2016-01-27 | シマベイ セラピューティクス, インコーポレーテッド | Composition of 5-ethyl-2- {4- [4- (4-tetrazol-1-yl-phenoxymethyl) -thiazol-2-yl] -piperidin-1-yl} -pyrimidine |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
CA2846496C (en) | 2011-09-02 | 2020-07-14 | The Regents Of The University Of California | Substituted pyrazolo[3,4-d]pyrimidines and uses thereof |
US20140004192A1 (en) * | 2012-04-13 | 2014-01-02 | Ziopharm Oncology, Inc. | Pharmaceutical formulations of indibulin and uses thereof |
BR112014030812B1 (en) | 2012-06-13 | 2022-11-08 | Incyte Holdings Corporation | SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS, THEIR USES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING A FGFR ENZYME |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
KR20150061651A (en) | 2012-09-26 | 2015-06-04 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Modulation of ire1 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
SG10201708520YA (en) | 2013-04-19 | 2017-12-28 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (en) | 2015-02-20 | 2017-12-26 | Incyte Corp | BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS |
AU2016219822B2 (en) | 2015-02-20 | 2020-07-09 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CN107722012B (en) * | 2016-08-11 | 2020-05-29 | 斯福瑞(南通)制药有限公司 | Process for preparing 4-chloro-7H-pyrrolo [2,3-d ] pyrimidines |
AR111960A1 (en) | 2017-05-26 | 2019-09-04 | Incyte Corp | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION |
KR20210018265A (en) | 2018-05-04 | 2021-02-17 | 인사이트 코포레이션 | Solid form of FGFR inhibitor and method for preparing same |
SG11202010882XA (en) | 2018-05-04 | 2020-11-27 | Incyte Corp | Salts of an fgfr inhibitor |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
JP2022552324A (en) | 2019-10-14 | 2022-12-15 | インサイト・コーポレイション | Bicyclic heterocycles as FGFR inhibitors |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
EP4069695A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Derivatives of an fgfr inhibitor |
AR126102A1 (en) | 2021-06-09 | 2023-09-13 | Incyte Corp | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0901786T3 (en) * | 1997-08-11 | 2007-10-08 | Pfizer Prod Inc | Solid pharmaceutical dispersions with increased bioavailability |
UA80171C2 (en) * | 2002-12-19 | 2007-08-27 | Pfizer Prod Inc | Pyrrolopyrimidine derivatives |
-
2006
- 2006-11-24 WO PCT/IB2006/003416 patent/WO2007066189A2/en active Application Filing
- 2006-11-27 NL NL2000337A patent/NL2000337A1/en active Search and Examination
- 2006-12-05 DO DO2006000271A patent/DOP2006000271A/en unknown
- 2006-12-06 PE PE2006001565A patent/PE20071037A1/en not_active Application Discontinuation
- 2006-12-06 UY UY29991A patent/UY29991A1/en not_active Application Discontinuation
- 2006-12-07 AR ARP060105422A patent/AR058293A1/en unknown
- 2006-12-07 GT GT200600496A patent/GT200600496A/en unknown
- 2006-12-08 TW TW095145947A patent/TW200733965A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL2000337A1 (en) | 2007-06-12 |
WO2007066189A3 (en) | 2008-08-14 |
GT200600496A (en) | 2007-07-17 |
DOP2006000271A (en) | 2007-08-15 |
WO2007066189A2 (en) | 2007-06-14 |
PE20071037A1 (en) | 2007-11-19 |
TW200733965A (en) | 2007-09-16 |
UY29991A1 (en) | 2007-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058293A1 (en) | PROFARMATIC SALTS AND FORMULATIONS OF 1- [5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO [2,3-D] PIRIMIDIN-5-CARBONIL) -2-METOXI-PHENIL] -3- (2,4- DICLOR-PHENYL) | |
ECSP055867A (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
NO20085060L (en) | Triazole pyrazine derivatives useful as anti-cancer agents | |
AR056873A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS QUINASA INHIBITORS OF CYCLINE DEPENDENTS, PHARMACEUTICAL COMPOSITIONS | |
CO5580767A2 (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE | |
ECSP056134A (en) | QUINUCLIDINE DERIVATIVES THAT LINK TO M3 MUSCARINIC RECEPTORS | |
EA200870448A1 (en) | PREPARATION OF 1,2,4-TRIAZOLES | |
EA201070588A1 (en) | DERIVATIVES 1,2,3-TRIAZOLE FOR USE AS STAROIL-COA DESSATRASE AS AN INHIBITORS | |
ECSP066950A (en) | ADRENOCEPTOR-BETA2 GLICOPIRROLATE AND AGONIST COMBINATIONS | |
EA201000805A1 (en) | BIS- (SULFONILAMINO) DERIVATIVES IN THERAPY 066 | |
AR080491A1 (en) | ORAL FORMULATIONS AND LIPOFILIC SALTS OF METHYLNTREXONE | |
AR047992A1 (en) | DIAMINOPIRIMIDINS AS ANTAGONISTS OF P2X3 AND P2X2 / 3 | |
ECSP066383A (en) | DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES | |
ECSP088549A (en) | NEW DERIVATIVES OF FUSIONATED PIRROL | |
NO20062004L (en) | Prolonged release pharmaceutical compositions include aplindor and derivatives thereof | |
DOP2001000170A (en) | USEFUL THIOPHEN DERIVATIVES AS ANTI-CHANCE AGENTS | |
UY29085A1 (en) | PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
EA201071094A1 (en) | TRIPLE-substituted 1,2,4-TRIAZOLES AS MODULATORS OF NICOTINE ACETYL-HOLINE RECEPTORS | |
UY30460A1 (en) | THERAPEUTIC COMPOUNDS | |
MXPA06002296A (en) | Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents. | |
CR9703A (en) | DERIVATIVES OF PIRAZOLONA | |
AR068919A1 (en) | 2- [3- (2,2-DIFLUORO-BENZO [1,3] DIOXOL-5-ILAMINO) -5- (2,6-DIMETIL-PIRIDIN-4-IL) [1,2,4] TRIAZOL-1 -IL] -N-ETHYL-ACETAMIDE AND ANALOGS OF THE SAME, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESS OF PREPARATION AND USE OF THE SAME IN PSYCHOTIC DISORDERS AND / OR DISEASES WITH INTELLECTUAL DIFFICULTIES. | |
AR056014A1 (en) | COMPOUND 3-AMINOCARBAZOL, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCEDURE FOR THE PREPARATION OF THE SAME | |
UY29510A1 (en) | DERIVATIVES OF UREA, METHODS FOR ITS MANUFACTURING, AND USES OF THE SAME | |
NO20083708L (en) | 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |